Symbols / ZIVO $1.32 -13.73% ZIVO Bioscience, Inc.
ZIVO Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Market Cap | 6.49M | Enterprise Value | — | Income | — | Sales | — | Book/sh | — | Cash/sh | — |
| Dividend Yield | — | Payout | — | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | — | P/C | — | EV/EBITDA | — | EV/Sales | — |
| Quick Ratio | — | Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | — | ROE | — | ROIC | — |
| Gross Margin | — | Oper. Margin | — | Profit Margin | — | Shs Outstand | — | Shs Float | — | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | — | 52W Low | — | Beta | — | Avg Volume | — |
| Volume | — | Target Price | — | Recom | — | Prev Close | $1.53 | Price | $1.32 | Change | -13.73% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- ZIVO plans to leave SEC reporting as lower costs target cash flow - Stock Titan Fri, 27 Mar 2026 07
- Insider Stock Purchases: February 17, 2026 - Quiver Quantitative ue, 17 Feb 2026 08
- A 96-acre Hawaii algae farm will make ZIVO's Zivolife biomass - Stock Titan Mon, 06 Apr 2026 07
- Zivo Bioscience, Inc. Announces Resignation of William A. Sullivan as Interim Chief Financial Officer, Effective March 30, 2026 - marketscreener.com Mon, 30 Mar 2026 07
- [EFFECT] Zivo Bioscience, Inc. SEC Filing - Stock Titan Wed, 01 Apr 2026 07
- Zivo Bioscience sees $1.51 million stock purchase by major investor By Investing.com - Investing.com ue, 31 Dec 2024 08
- Director and 10% Owner Christopher Maggiore Acquires 31,336 Shares of Zivo Bioscience Inc (ZIVO) - Yahoo Finance Fri, 23 Aug 2024 07
- [POS AM] Zivo Bioscience, Inc. SEC Filing - Stock Titan Mon, 30 Mar 2026 07
- Zivo Bioscience Stock Price Forecast. Should You Buy ZIVO? - StockInvest.us Sat, 12 Dec 2020 11
- Zivo Bioscience procures USD 1 mln finance for its new coccidiosis product - World Business Outlook hu, 06 Apr 2023 07
- Maggiore buys Zivo Bioscience shares worth $14,993 - Investing.com ue, 27 Jan 2026 08
- Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq - GlobeNewswire Wed, 02 Jun 2021 07
- ZIVO Bioscience (OTCQB: ZIVO) plans Form 15 to exit SEC reporting - Stock Titan Mon, 30 Mar 2026 07
- Form 8-K - Current report - ADVFN Mon, 27 Jan 2025 08
- Top FibroBiologics (FBLG) Competitors 2026 - MarketBeat hu, 01 Feb 2024 03
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.16
+468.61%
|
0.03
|
0.00
|
0.00
|
| Operating Revenue |
|
0.16
+468.61%
|
0.03
|
0.00
|
0.00
|
| Cost Of Revenue |
|
0.11
+574.99%
|
0.02
|
0.00
|
—
|
| Reconciled Cost Of Revenue |
|
0.11
+574.99%
|
0.02
|
0.00
|
—
|
| Gross Profit |
|
0.05
+321.64%
|
0.01
|
0.00
|
—
|
| Operating Expense |
|
13.41
+84.35%
|
7.27
-16.69%
|
8.73
+1.00%
|
8.65
|
| Research And Development |
|
3.13
+127.66%
|
1.38
-38.53%
|
2.24
+14.86%
|
1.95
|
| Selling General And Administration |
|
10.28
+74.24%
|
5.90
-9.15%
|
6.49
-3.03%
|
6.69
|
| General And Administrative Expense |
|
10.28
+74.24%
|
5.90
-9.15%
|
6.49
-3.03%
|
6.69
|
| Other Gand A |
|
10.28
+74.24%
|
5.90
-9.15%
|
6.49
-3.03%
|
6.69
|
| Total Expenses |
|
13.52
+85.43%
|
7.29
-16.51%
|
8.73
+1.00%
|
8.65
|
| Operating Income |
|
-13.36
-83.97%
|
-7.26
+16.82%
|
-8.73
-1.00%
|
-8.65
|
| Total Operating Income As Reported |
|
-13.36
-83.97%
|
-7.26
+16.82%
|
-8.73
-1.00%
|
-8.65
|
| EBITDA |
|
-13.36
-83.97%
|
-7.26
+16.82%
|
-8.73
-2.46%
|
-8.52
|
| Normalized EBITDA |
|
-13.36
-83.97%
|
-7.26
+16.82%
|
-8.73
-1.00%
|
-8.65
|
| EBIT |
|
-13.36
-83.97%
|
-7.26
+16.82%
|
-8.73
-2.46%
|
-8.52
|
| Total Unusual Items |
|
—
|
—
|
0.00
-100.00%
|
0.12
|
| Total Unusual Items Excluding Goodwill |
|
—
|
—
|
0.00
-100.00%
|
0.12
|
| Special Income Charges |
|
—
|
—
|
0.00
-100.00%
|
0.12
|
| Other Special Charges |
|
—
|
—
|
—
|
-0.12
|
| Net Income |
|
-13.38
-72.10%
|
-7.78
+11.07%
|
-8.75
+0.12%
|
-8.76
|
| Pretax Income |
|
-13.38
-72.10%
|
-7.78
+11.07%
|
-8.75
+0.12%
|
-8.76
|
| Net Non Operating Interest Income Expense |
|
-0.02
+95.54%
|
-0.51
-3760.44%
|
-0.01
+94.29%
|
-0.23
|
| Interest Expense Non Operating |
|
0.02
-95.54%
|
0.51
+3760.44%
|
0.01
-94.29%
|
0.23
|
| Net Interest Income |
|
-0.02
+95.54%
|
-0.51
-3760.44%
|
-0.01
+94.29%
|
-0.23
|
| Interest Expense |
|
0.02
-95.54%
|
0.51
+3760.44%
|
0.01
-94.29%
|
0.23
|
| Other Income Expense |
|
—
|
—
|
—
|
0.12
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-13.38
-72.10%
|
-7.78
+11.07%
|
-8.75
+0.12%
|
-8.76
|
| Net Income From Continuing Operation Net Minority Interest |
|
-13.38
-72.10%
|
-7.78
+11.07%
|
-8.75
+0.12%
|
-8.76
|
| Net Income From Continuing And Discontinued Operation |
|
-13.38
-72.10%
|
-7.78
+11.07%
|
-8.75
+0.12%
|
-8.76
|
| Net Income Continuous Operations |
|
-13.38
-72.10%
|
-7.78
+11.07%
|
-8.75
+0.12%
|
-8.76
|
| Normalized Income |
|
-13.38
-72.10%
|
-7.78
+11.07%
|
-8.75
+1.50%
|
-8.88
|
| Net Income Common Stockholders |
|
-13.38
-72.10%
|
-7.78
+11.07%
|
-8.75
+0.12%
|
-8.76
|
| Diluted EPS |
|
-4.23
+8.04%
|
-4.60
+17.41%
|
-5.57
+19.28%
|
-6.90
|
| Basic EPS |
|
-4.23
+8.04%
|
-4.60
+17.41%
|
-5.57
+19.28%
|
-6.90
|
| Basic Average Shares |
|
3.17
+87.40%
|
1.69
+7.65%
|
1.57
+23.47%
|
1.27
|
| Diluted Average Shares |
|
3.17
+87.40%
|
1.69
+7.65%
|
1.57
+23.47%
|
1.27
|
| Diluted NI Availto Com Stockholders |
|
-13.38
-72.10%
|
-7.78
+11.07%
|
-8.75
+0.12%
|
-8.76
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
1.64
+195.68%
|
0.56
-73.82%
|
2.12
-76.39%
|
8.99
|
| Current Assets |
|
1.64
+284.47%
|
0.43
-77.63%
|
1.90
-78.78%
|
8.96
|
| Cash Cash Equivalents And Short Term Investments |
|
1.54
+462.16%
|
0.27
-84.75%
|
1.80
-79.79%
|
8.90
|
| Cash And Cash Equivalents |
|
1.54
+462.16%
|
0.27
-84.75%
|
1.80
-79.79%
|
8.90
|
| Cash Financial |
|
1.54
+462.16%
|
0.27
-84.75%
|
1.80
-79.79%
|
8.90
|
| Receivables |
|
0.00
-40.80%
|
0.00
|
0.00
|
—
|
| Accounts Receivable |
|
0.00
-40.80%
|
0.00
|
0.00
|
—
|
| Gross Accounts Receivable |
|
—
|
0.00
|
0.00
|
—
|
| Prepaid Assets |
|
0.09
-38.35%
|
0.15
+43.79%
|
0.10
+76.34%
|
0.06
|
| Total Non Current Assets |
|
0.01
-94.11%
|
0.13
-41.11%
|
0.22
+632.31%
|
0.03
|
| Net PPE |
|
0.00
-100.00%
|
0.10
-48.08%
|
0.19
+595.25%
|
0.03
|
| Gross PPE |
|
0.00
-100.00%
|
0.10
-48.08%
|
0.19
+595.25%
|
0.03
|
| Accumulated Depreciation |
|
—
|
—
|
—
|
-0.10
|
| Machinery Furniture Equipment |
|
—
|
—
|
—
|
0.02
|
| Other Properties |
|
—
|
0.10
-48.08%
|
0.19
+595.25%
|
0.03
|
| Non Current Prepaid Assets |
|
0.01
-76.04%
|
0.03
+0.00%
|
0.03
+968.60%
|
0.00
|
| Total Liabilities Net Minority Interest |
|
2.16
-21.86%
|
2.76
+29.43%
|
2.13
-27.62%
|
2.95
|
| Current Liabilities |
|
2.04
-26.06%
|
2.76
+36.19%
|
2.03
-31.22%
|
2.95
|
| Payables And Accrued Expenses |
|
0.81
-36.24%
|
1.27
+115.03%
|
0.59
-21.50%
|
0.75
|
| Payables |
|
0.74
-36.36%
|
1.17
+137.59%
|
0.49
-25.01%
|
0.65
|
| Accounts Payable |
|
0.55
-44.91%
|
0.99
+102.39%
|
0.49
-25.01%
|
0.65
|
| Current Accrued Expenses |
|
0.07
-34.82%
|
0.10
+2.44%
|
0.10
+2.50%
|
0.10
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
1.10
-4.58%
|
1.15
+188.51%
|
0.40
-14.78%
|
0.47
|
| Current Debt And Capital Lease Obligation |
|
0.14
-60.11%
|
0.35
+2.09%
|
0.34
+32.95%
|
0.26
|
| Current Debt |
|
0.14
-42.43%
|
0.24
+0.00%
|
0.24
+0.00%
|
0.24
|
| Other Current Borrowings |
|
0.14
-42.43%
|
0.24
+0.00%
|
0.24
+0.00%
|
0.24
|
| Current Capital Lease Obligation |
|
0.00
-100.00%
|
0.11
+7.14%
|
0.10
+553.97%
|
0.02
|
| Current Deferred Liabilities |
|
—
|
0.00
-100.00%
|
0.70
-52.46%
|
1.48
|
| Total Non Current Liabilities Net Minority Interest |
|
0.12
|
0.00
-100.00%
|
0.11
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
0.12
|
0.00
-100.00%
|
0.11
|
0.00
|
| Long Term Debt |
|
0.12
|
—
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
—
|
0.00
-100.00%
|
0.11
|
0.00
|
| Stockholders Equity |
|
-0.51
+76.66%
|
-2.21
-20666.74%
|
-0.01
-100.18%
|
6.04
|
| Common Stock Equity |
|
-0.51
+76.66%
|
-2.21
-20666.74%
|
-0.01
-100.18%
|
6.04
|
| Capital Stock |
|
0.00
+51.95%
|
0.00
+51.78%
|
0.00
-83.33%
|
0.01
|
| Common Stock |
|
0.00
+51.95%
|
0.00
+51.78%
|
0.00
-83.33%
|
0.01
|
| Share Issued |
|
3.62
+52.01%
|
2.38
+51.75%
|
1.57
+0.00%
|
1.57
|
| Ordinary Shares Number |
|
3.62
+52.01%
|
2.38
+51.75%
|
1.57
+0.00%
|
1.57
|
| Additional Paid In Capital |
|
136.45
+12.42%
|
121.37
+4.82%
|
115.79
+2.39%
|
113.09
|
| Retained Earnings |
|
-136.97
-10.83%
|
-123.58
-6.72%
|
-115.80
-8.17%
|
-107.06
|
| Total Equity Gross Minority Interest |
|
-0.51
+76.66%
|
-2.21
-20666.74%
|
-0.01
-100.18%
|
6.04
|
| Total Capitalization |
|
-0.40
+81.93%
|
-2.21
-20666.74%
|
-0.01
-100.18%
|
6.04
|
| Working Capital |
|
-0.41
+82.60%
|
-2.34
-1753.48%
|
-0.13
-102.10%
|
6.01
|
| Invested Capital |
|
-0.26
+86.75%
|
-1.97
-957.03%
|
0.23
-96.35%
|
6.28
|
| Total Debt |
|
0.25
-26.56%
|
0.35
-22.20%
|
0.45
+74.46%
|
0.26
|
| Capital Lease Obligations |
|
0.00
-100.00%
|
0.11
-48.17%
|
0.21
+1251.81%
|
0.02
|
| Net Tangible Assets |
|
-0.51
+76.66%
|
-2.21
-20666.74%
|
-0.01
-100.18%
|
6.04
|
| Tangible Book Value |
|
-0.51
+76.66%
|
-2.21
-20666.74%
|
-0.01
-100.18%
|
6.04
|
| Dueto Related Parties Current |
|
0.19
+12.79%
|
0.17
|
0.00
|
—
|
| Interest Payable |
|
0.07
-34.82%
|
0.10
+2.44%
|
0.10
+2.50%
|
0.10
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.31
+25.63%
|
-5.80
+18.34%
|
-7.10
-4.40%
|
-6.80
|
| Cash Flow From Continuing Operating Activities |
|
-4.31
+25.63%
|
-5.80
+18.34%
|
-7.10
-4.40%
|
-6.80
|
| Net Income From Continuing Operations |
|
-13.38
-72.10%
|
-7.78
+11.07%
|
-8.75
+0.12%
|
-8.76
|
| Other Non Cash Items |
|
0.10
+157.56%
|
-0.17
+75.41%
|
-0.69
-38.65%
|
-0.50
|
| Stock Based Compensation |
|
9.47
+992.23%
|
0.87
-67.79%
|
2.69
-9.35%
|
2.97
|
| Operating Gains Losses |
|
—
|
—
|
—
|
-0.12
|
| Gain Loss On Investment Securities |
|
—
|
—
|
—
|
0.03
|
| Change In Working Capital |
|
-0.50
-139.08%
|
1.28
+460.35%
|
-0.36
+9.83%
|
-0.39
|
| Change In Receivables |
|
0.00
+140.80%
|
-0.00
|
0.00
|
—
|
| Changes In Account Receivables |
|
0.00
+140.80%
|
-0.00
|
0.00
|
—
|
| Change In Prepaid Assets |
|
0.08
+280.29%
|
-0.04
+38.90%
|
-0.07
-160.96%
|
-0.03
|
| Change In Payables And Accrued Expense |
|
-0.48
-133.37%
|
1.43
+720.09%
|
-0.23
+45.44%
|
-0.42
|
| Change In Accrued Expense |
|
-0.05
-106.98%
|
0.75
+1229.96%
|
-0.07
-113.79%
|
0.48
|
| Change In Payable |
|
-0.42
-162.79%
|
0.68
+512.49%
|
-0.16
+81.92%
|
-0.91
|
| Change In Account Payable |
|
-0.42
-162.79%
|
0.68
+512.49%
|
-0.16
+81.92%
|
-0.91
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
0.09
|
| Change In Other Current Liabilities |
|
-0.11
-7.60%
|
-0.10
-91.19%
|
-0.05
-77.21%
|
-0.03
|
| Investing Cash Flow |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Financing Cash Flow |
|
5.58
+30.56%
|
4.28
|
0.00
-100.00%
|
15.57
|
| Cash Flow From Continuing Financing Activities |
|
5.58
+30.56%
|
4.28
|
0.00
-100.00%
|
15.57
|
| Net Issuance Payments Of Debt |
|
-0.02
|
0.00
|
0.00
|
0.00
|
| Issuance Of Debt |
|
0.52
-70.52%
|
1.76
+179.29%
|
0.63
+229.97%
|
0.19
|
| Repayment Of Debt |
|
-0.54
+69.34%
|
-1.76
-179.29%
|
-0.63
-229.97%
|
-0.19
|
| Long Term Debt Issuance |
|
0.52
-70.52%
|
1.76
+179.29%
|
0.63
+229.97%
|
0.19
|
| Long Term Debt Payments |
|
-0.54
+69.34%
|
-1.76
-179.29%
|
-0.63
-229.97%
|
-0.19
|
| Net Long Term Debt Issuance |
|
-0.02
|
0.00
|
0.00
|
0.00
|
| Short Term Debt Issuance |
|
—
|
1.76
+179.29%
|
0.63
|
—
|
| Short Term Debt Payments |
|
—
|
-1.76
-179.29%
|
-0.63
|
—
|
| Net Short Term Debt Issuance |
|
—
|
0.00
|
0.00
|
—
|
| Net Common Stock Issuance |
|
5.60
+775.35%
|
0.64
|
0.00
-100.00%
|
17.21
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
3.64
|
0.00
-100.00%
|
0.06
|
| Net Other Financing Charges |
|
—
|
—
|
—
|
-1.70
|
| Changes In Cash |
|
1.27
+183.16%
|
-1.52
+78.53%
|
-7.10
-181.04%
|
8.76
|
| Beginning Cash Position |
|
0.27
-84.75%
|
1.80
-79.79%
|
8.90
+6357.09%
|
0.14
|
| End Cash Position |
|
1.54
+462.16%
|
0.27
-84.75%
|
1.80
-79.79%
|
8.90
|
| Free Cash Flow |
|
-4.31
+25.63%
|
-5.80
+18.34%
|
-7.10
-4.40%
|
-6.80
|
| Interest Paid Supplemental Data |
|
0.02
-73.74%
|
0.07
+560.97%
|
0.01
+254.09%
|
0.00
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
5.60
+775.35%
|
0.64
|
0.00
-100.00%
|
17.21
|
| Issuance Of Capital Stock |
|
5.60
+775.35%
|
0.64
|
0.00
-100.00%
|
17.21
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-30 View
- 42026-03-03 View
- 42026-02-17 View
- 42026-02-12 View
- 42026-01-28 View
- 42026-01-28 View
- 42026-01-27 View
- 42026-01-27 View
- 8-K2025-12-23 View
- 42025-12-02 View
- 10-Q2025-11-14 View
- 42025-10-20 View
- 42025-10-14 View
- 42025-10-09 View
- 42025-10-06 View
- 42025-10-06 View
- 42025-10-06 View
- 42025-10-02 View
- 8-K2025-09-10 View
- 8-K2025-08-18 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|